WallStSmart

Kimberly-Clark Corporation (KMB)vsNu Skin Enterprises Inc (NUS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Kimberly-Clark Corporation generates 954% more annual revenue ($16.45B vs $1.56B). KMB leads profitability with a 12.3% profit margin vs 7.0%. NUS appears more attractively valued with a PEG of 0.78. NUS earns a higher WallStSmart Score of 67/100 (B-).

KMB

Buy

52

out of 100

Grade: C-

Growth: 3.3Profit: 7.5Value: 6.0Quality: 4.0
Piotroski: 3/9Altman Z: 2.19

NUS

Strong Buy

67

out of 100

Grade: B-

Growth: 4.7Profit: 5.5Value: 10.0Quality: 8.5
Piotroski: 5/9Altman Z: 4.17
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KMBUndervalued (+9.3%)

Margin of Safety

+9.3%

Fair Value

$118.58

Current Price

$99.36

$19.22 discount

UndervaluedFair: $118.58Overvalued
NUSUndervalued (+90.1%)

Margin of Safety

+90.1%

Fair Value

$102.49

Current Price

$7.29

$95.20 discount

UndervaluedFair: $102.49Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KMB1 strengths · Avg: 10.0/10
Return on EquityProfitability
126.6%10/10

Every $100 of equity generates 127 in profit

NUS5 strengths · Avg: 9.6/10
P/E RatioValuation
4.5x10/10

Attractively priced relative to earnings

Price/BookValuation
0.4x10/10

Reasonable price relative to book value

EPS GrowthGrowth
103.6%10/10

Earnings expanding 103.6% YoY

Altman Z-ScoreHealth
4.1710/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.788/10

Growing faster than its price suggests

Areas to Watch

KMB4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
6.892/10

Expensive relative to growth rate

Price/BookValuation
21.9x2/10

Trading at 21.9x book value

Revenue GrowthGrowth
-0.6%2/10

Revenue declined 0.6%

NUS3 concerns · Avg: 2.7/10
Market CapQuality
$476.78M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
7.0%3/10

7.0% margin — thin

Revenue GrowthGrowth
-15.3%2/10

Revenue declined 15.3%

Comparative Analysis Report

WallStSmart Research

Bull Case : KMB

The strongest argument for KMB centers on Return on Equity.

Bull Case : NUS

The strongest argument for NUS centers on P/E Ratio, Price/Book, EPS Growth. PEG of 0.78 suggests the stock is reasonably priced for its growth.

Bear Case : KMB

The primary concerns for KMB are Piotroski F-Score, PEG Ratio, Price/Book. Debt-to-equity of 4.77 is elevated, increasing financial risk.

Bear Case : NUS

The primary concerns for NUS are Market Cap, Profit Margin, Revenue Growth.

Key Dynamics to Monitor

KMB profiles as a declining stock while NUS is a value play — different risk/reward profiles.

NUS carries more volatility with a beta of 0.98 — expect wider price swings.

KMB is growing revenue faster at -0.6% — sustainability is the question.

KMB generates stronger free cash flow (575M), providing more financial flexibility.

Bottom Line

NUS scores higher overall (67/100 vs 52/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Kimberly-Clark Corporation

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Kimberly-Clark Corporation is an American multinational personal care corporation that produces mostly paper-based consumer products. The company manufactures sanitary paper products and surgical & medical instruments. Kimberly-Clark brand name products include Kleenex facial tissue, Kotex feminine hygiene products, Cottonelle, Scott and Andrex toilet paper, Wypall utility wipes, KimWipes scientific cleaning wipes and Huggies disposable diapers and baby wipes.

Visit Website →

Nu Skin Enterprises Inc

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Nu Skin Enterprises, Inc. develops and distributes wellness and personal care products globally. The company is headquartered in Provo, Utah.

Visit Website →

Want to dig deeper into these stocks?